TCL Archive Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research September 13, 1996
TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific August 12, 2011
TCL Archive Senate Gives NCI More Money, Fewer Strings, Orders Grants Paid At Recommended Levels October 7, 1983
TCL Archive After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA April 14, 1995